Indeed, tamoxifen-resistant breast cancer cells over-expressed MRP2 that in the promoter region contains four FOXO binding sites, a finding that renders FoxO1 a regulator of MRP2-mediated resistance [85]. This evidence concerns the gene FOXO1 and breast carcinoma.